Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Ozanezumab> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Ozanezumab abstract "Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis.Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4. NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with MND.This drug was developed by GlaxoSmithKline under the identifier GSK 1223249.".
- Ozanezumab atcPrefix "none".
- Ozanezumab casNumber "1310680-64-8".
- Ozanezumab wikiPageExternalLink A-Go-For-anti-NOGO-A.aspx?utm_source=ALS+Digest+April+12%2C+2013&utm_campaign=Prize4Life+Digest&utm_medium=email.
- Ozanezumab wikiPageExternalLink phase-ii-ozanezumab-gsk1223249.
- Ozanezumab wikiPageExternalLink result_detail.jsp?protocolId=111330&studyId=6B53306A-9CFF-42EE-987C-B5D9F45BA40B&compound=GSK1223249.
- Ozanezumab wikiPageExternalLink result_detail.jsp?protocolId=112988&studyId=02EEC5BE-1F88-4808-BEB8-B4E7730088D9&compound=GSK1223249.
- Ozanezumab wikiPageExternalLink result_detail.jsp?protocolId=114840&studyId=008EEB15-83CB-491B-90FC-BDF2755BB100&compound=GSK1223249.
- Ozanezumab wikiPageExternalLink 7400826.html.
- Ozanezumab wikiPageExternalLink S030100820900077X.
- Ozanezumab wikiPageID "36964625".
- Ozanezumab wikiPageLength "5080".
- Ozanezumab wikiPageOutDegree "5".
- Ozanezumab wikiPageRevisionID "707385557".
- Ozanezumab wikiPageWikiLink Category:GlaxoSmithKline.
- Ozanezumab wikiPageWikiLink GlaxoSmithKline.
- Ozanezumab wikiPageWikiLink Monoclonal_antibody.
- Ozanezumab wikiPageWikiLink Multiple_sclerosis.
- Ozanezumab wikiPageWikiLink Reticulon_4.
- Ozanezumab wikiPageWikiLinkText "Ozanezumab".
- Ozanezumab wikiPageWikiLinkText "ozanezumab".
- Ozanezumab atcPrefix "none".
- Ozanezumab c "6446".
- Ozanezumab casNumber "1310680".
- Ozanezumab chemspiderid "none".
- Ozanezumab h "10016".
- Ozanezumab molecularWeight "145.2".
- Ozanezumab n "1712".
- Ozanezumab o "2010".
- Ozanezumab s "48".
- Ozanezumab source "zu/o".
- Ozanezumab target "Nogo-A".
- Ozanezumab type "mab".
- Ozanezumab wikiPageUsesTemplate Template:Drugbox.
- Ozanezumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Ozanezumab subject Category:GlaxoSmithKline.
- Ozanezumab hypernym Antibody.
- Ozanezumab type ChemicalSubstance.
- Ozanezumab type Company.
- Ozanezumab type Drug.
- Ozanezumab type Antibody.
- Ozanezumab type Chemical.
- Ozanezumab type Company.
- Ozanezumab type Drug.
- Ozanezumab type ChemicalObject.
- Ozanezumab type Thing.
- Ozanezumab type Q8386.
- Ozanezumab comment "Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis.Ozanezumab targets a protein called Neurite Outgrowth Inhibitor (NOGO-A) or Reticulon 4. NOGO-A is a protein that in humans is encoded by the RTN4 gene that has been identified as an inhibitor of neurite outgrowth specific to the central nervous system. NOGO-A is found at higher than normal levels in persons with MND.This drug was developed by GlaxoSmithKline under the identifier GSK 1223249.".
- Ozanezumab label "Ozanezumab".
- Ozanezumab sameAs Q7116457.
- Ozanezumab sameAs m.0n48f_w.
- Ozanezumab sameAs Q7116457.
- Ozanezumab wasDerivedFrom Ozanezumab?oldid=707385557.
- Ozanezumab isPrimaryTopicOf Ozanezumab.